Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast CancerIshwar N. Kohale, Forest M. White, Jia Yu et al.|Cancers|2022Cited by 24
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)Yongxian Zhuang, Liewei Wang|npj Breast Cancer|2021Cited by 11
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination StrategiesIda Aronchik, Mallika Singh, Kevin Yang et al.|Molecular Cancer Therapeutics|2025Cited by 1